Is LRCX a good stock to buy? We came across a bullish thesis on Lam Research Corporation on Nikhs’s Substack In this article, we will summarize the bulls’ thesis on LRCX. Lam Research Corporation's share was trading at $258.57 as of May 4th. LRCX’s trailing and forw
Bitcoin price targets $79K as US PPI inflation hits highest since 2022 Bitcoin slipped further below the $80,000 mark as US PPI data compounded the inflation problem from the US-Iran war and associated high oil prices. Bitcoin (BTC) fell below $80,000 into Wednesday’s Wall
Crypto wallet provider Ledger has put its U.S. IPO plans on hold due to unfavorable market conditions People familiar with the matter said Ledger has not filed any draft S-1 registration statement with the U.S. SEC and may consider alternatives such as private fundr
Analysis suggests bitcoin is increasingly competing with gold as a store of value, with a 26% relative undervaluation. Bitcoin’s classification as a risk asset may be evolving as it competes with gold for macro allocation, according to new analysis. The digital asset share
Shopify (SHOP) has appeared on a screener of stocks sitting below their 50-day and 200-day moving averages. With shares of the e-commerce platform company under severe pressure, there is a chance they could drop to around 90 in the next few weeks Let's look at a but
KeyBanc lowers On Holding’s price target amid $70.43M in Q1 tariff costs but maintains Overweight rating on growth outlook. KeyBanc reduced its price target for On Holding (ONON) to $43 from $58, citing tariff pressures from Vietnam sourcing concentration. The firm maintai
The company posted $3.9 million adjusted EBITDA for the quarter, driven by zinc operations and new critical mineral initiatives. Titan Mining reported a 22% year-over-year increase in Q1 2026 revenue, reaching $19.6 million, supported by steady zinc sales volumes and cost
Takeda Pharmaceutical Company Ltd. (NYSE:TAK) reported fourth-quarter sales of $6.98 billion, or 1.094 trillion yen, missing Wall Street estimates of $7.05 billion. The Japanese drugmaker reported adjusted earnings of 28 cents per ADR (89 yen per share), beating analyst es
Nvidia stock surged to an all-time high amid optimism over U.S.-China trade talks and strong AI-driven chip demand. Nvidia (NVDA) shares reached a record high Wednesday, extending a winning streak to 11 sessions, the longest since its 1999 trading debut. The rally was fuel
Corcept Therapeutics rises 7% after UBS upgrade Corcept Therapeutics jumped more than 7% on Wednesday. The upgrade to Buy from Neutral by UBS Group also included a raised price target to $72 from $44. This implies nearly 41% upside from Tuesday's close of $51.16.